$CVAT: From Quiet Negotiations to a $40M Buyout | Why This Changes the Story

By Eric J. Kemnitzer

Sometimes a press release hits… and sometimes it completely shifts the narrative.

That’s exactly what just happened with Cavitation Technologies (OTCQB: $CVAT).

The company has received a $40–$42 million all-cash buyout Letter of Intent, and if you’ve been following this story, you know this isn’t just another OTC headline, it’s a potential turning point.

From Momentum… to Something Much Bigger

$CVAT already had a notable run last fall, gaining attention across the OTC space. But in recent months, the company went relatively quiet.

Now we know why.

Behind the scenes, management confirms they were actively working through negotiations, positioning assets, and laying the groundwork for what has now materialized into a multi-million dollar acquisition proposal. Clearly, this was their intent.

It’s Not Just About $0.13

The headline number, approximately $0.13 per share fully diluted, is important. But focusing only on that misses the bigger picture. This proposed deal includes the company’s broader ecosystem:

• Core Cavitation Technologies business

• XYRA, a developing fintech and crypto infrastructure platform

• Alchemy, tied to consumer-facing innovation

  
  

What stands out is that some of these assets may not yet be fully reflected in the company’s financials. That creates a meaningful gap between current valuation and future potential.

That’s where things get interesting. The market may not yet be pricing in what’s actually being built here, while the buyer may already be factoring in that upside. As the Neil Voloshin put it:

“We have other pieces to the puzzle.”

A Structured Process

This is where things become more compelling. The LOI marks the beginning of a process, not the end of one. Several key steps still need to play out before anything is finalized, including:

• A third-party fairness opinion to evaluate valuation

• Proof of funds within 10 days

• Legal, financial, and patent due diligence

• A shareholder vote to approve the transaction

Management has made it clear that this will be handled with discipline and a focus on shareholder value. Neil Voloshin emphasized this directly, stating:

“I’m not gonna shortchange anybody.” 

That statement reinforces an important point, this is not about accepting the first offer, but about validating and negotiating the best possible outcome.

The First Major Catalyst: Proof of Funds

One of the most important near-term developments is the requirement for the buyer to provide verified proof of funds within 10 days. This is a critical step because it:

• Confirms the seriousness of the buyer

• Transitions the LOI from concept to credibility

• Signals whether the deal has real closing potential

  
  

Management also noted that this is not a cold outreach situation, and that there is an existing relationship with the acquiring group, adding another layer of confidence to the process.

Exclusivity, Leverage, and Negotiation

The 60-day exclusivity period may raise questions at first glance, but it’s important to understand how it fits into the broader strategy.

While the company cannot actively solicit competing offers during this window, it does not eliminate leverage. In fact, there are already indications that interest in the company extends beyond this single proposal.

That detail matters. It suggests that CVAT is not operating in a vacuum and that external interest could still influence how negotiations evolve. Combined with the upcoming fairness opinion and ongoing discussions, this remains a very active and fluid situation.

What This Means for Shareholders

If the transaction is completed, the likely outcome is that the company would be taken private.

That process would involve:

• A formal shareholder vote (proxy process)

• Approval thresholds to move forward

• A cash payout structure for shareholders

  
  

For investors, this presents a clear question:

Is this an opportunity for liquidity… or is the company being acquired before its full potential is realized?

🔥 BFC TAKEAWAY & FINAL THOUGHTS

$CVAT has officially shifted from a speculative OTC story into a deal-driven situation with real structure and defined catalysts. While this buyout is not finalized, the presence of a $40–$42M all-cash LOI introduces a level of credibility and urgency that changes how this ticker should be viewed. This is now a dynamic setup where each step in the process; funding verification, valuation, and negotiations, has the potential to move sentiment and price quickly.

What makes this especially compelling is the combination of a live acquisition scenario alongside developing assets like XYRA, which may not yet be fully reflected in current valuation. Whether this deal closes as is, improves, or leads to alternative outcomes, the landscape around $CVAT has clearly evolved.

Key points to watch moving forward:

• Proof of funds within 10 days (major near-term catalyst)

• Results of the independent fairness opinion

• Any updates from ongoing negotiations or additional interest

• Shareholder vote structure and potential privatization path

• Continued development and positioning of XYRA and core assets

  
  

This is not a guaranteed outcome, but it is a highly active situation with multiple potential paths, making it one of the more interesting setups currently in the OTC space.

FULL INTERVIEW: https://www.youtube.com/watch?v=04GWUfQw68A&t=2s

Disclaimer: This article is for informational purposes only and is not financial advice. Always conduct your own due diligence.